Short answer
CYTOKINETICS INC (CYTK) filed an 8-K current report with the SEC on August 13, 2026 reporting Item 8.01 (Other Events). Cytokinetics filed a Delaware lawsuit against Bristol-Myers Squibb and MyoKardia over U.S. Patent No. 12,616,697.
CYTOKINETICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Cytokinetics filed a Delaware lawsuit against Bristol-Myers Squibb and MyoKardia over U.S. Patent No. 12,616,697
- Declaratory judgment seeks findings that MYQORZO (aficamten) does not infringe and the patent claims are invalid
- Requested injunction would bar infringement threats against Cytokinetics and MYQORZO customers, suppliers, distributors
- Litigation outcome remains uncertain, creating potential legal and commercial risk for MYQORZO
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CYTOKINETICS INC 8-K filings
Get the next CYTK 8-K as it lands
Follow CYTK for push alerts, or ask the research agent what this filing means.